---
title: 4BIO Capital - Startup Match Score & Focus Areas
description: Is 4BIO Capital the right VC for you? See how their thesis aligns with your startup and discover more active investors focusing on cell and gene therapy and RNA-based therapeutics.
---

[![Höpöhöpö_logo_black](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/H%C3%B6p%C3%B6h%C3%B6p%C3%B6_logo_black.png)](https://www.hopohopo.io/?hsLang=io)

- [For Startups](https://www.hopohopo.io?hsLang=io)
- For Investors & Accelerators
  
    - [Screen your deal flow with AI](https://www.hopohopo.io/for-investors?hsLang=io)
    - [Source deals from co-investors and accelerators](https://www.hopohopo.io/source-deal-flow?hsLang=io)
    - [Help your portfolio fundraise](https://www.hopohopo.io/portfolio-fundraising?hsLang=io)
- [For BANs](https://www.hopohopo.io/business-angel-networks?hsLang=io)
- [Pricing](https://www.hopohopo.io/pricing?hsLang=io)
- Resources
  
    - [Maritime Venture program](https://maritime-venture.com/)
    - [Startup Fundraising Essentials](https://www.hopohopo.io/fundraising-essentials?hsLang=io)
    - Investor lists 
          - [EdTech investors in Europe](https://www.hopohopo.io/edtech-investors?hsLang=io)
          - [FinTech investors in Europe](https://www.hopohopo.io/fintech-investors?hsLang=io)
          - [HealthTech investors in Europe](https://www.hopohopo.io/healthtech-investors?hsLang=io)
          - [Climate & Sustainability investors](https://www.hopohopo.io/climate-and-sustainability-investors?hsLang=io)
          - [Gaming investors](https://www.hopohopo.io/gaming-investors?hsLang=io)
          - [SpaceTech investors](https://www.hopohopo.io/spacetech-investors?hsLang=io)
          - [SportsTech investors](https://www.hopohopo.io/sporttech-investors?hsLang=io)
          - [Enterprise Software investors](https://www.hopohopo.io/enterprise-software-investors?hsLang=io)
          - [DefSec investors](https://www.hopohopo.io/defsec-investors?hsLang=io)
          - [Marine Tech investors](https://www.hopohopo.io/marinetech-investors?hsLang=io)
          - [Mobility investors](https://www.hopohopo.io/mobility-investors?hsLang=io)
          - [PropTech investors](https://www.hopohopo.io/proptech-investors?hsLang=io)
          - [Energy investors](https://www.hopohopo.io/energy-investors?hsLang=io)
          - [Top 10 Active investors in Berlin](https://www.hopohopo.io/top-investors-berlin?hsLang=io)

[Log in](https://start.hopohopo.io/) [Sign up](https://start.hopohopo.io/?signup=true)

# 4BIO Capital Overview

 4BIO Capital is a London-based venture capital firm focused solely on the advanced therapies sector. The firm aims to invest in, support, and grow early-stage companies developing treatments in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially curative therapies for all patients. Specifically, 4BIO Capital seeks opportunities in cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome. The team comprises leading advanced therapy scientists and experienced life science investors who have collectively published over 250 scientific articles in prestigious academic journals, including Nature, The Lancet, Cell, and the New England Journal of Medicine. This expertise provides 4BIO with an unrivaled network within the advanced therapy sector and a unique understanding of the criteria that define a successful investment opportunity in this space.

 Is 4BIO Capital the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with 4BIO Capital, along with a list of other relevant VCs, is available on Hopohopo.io.

## 4BIO Capital

 VC Fund

![4BIO Capital logo](https://www.hopohopo.io/hubfs/ecosystem-logos-from-platform/7507-1a706f5847b2724986a7f0064a0fef32.jpeg)

## Investment focus

### Invest in

- Baltics
- Nordics
- Western Europe
- Southern Europe
- Central Eastern Europe
- Caribbean

[View all](https://start.hopohopo.io/?signup=true)

### Product type

- Drugs / Pharma

### Industries / verticals

- BioTech & Life Sciences
- PharmaTech

Investment role

 Lead and follow

Stages

 Series A, Series B or later

First ticket size

 £1,000,000 - £75,000,000

## Contact information

Chief Operating Officer

Vasily Fedorin

![LinkedIn](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/H%C3%B6p%C3%B6h%C3%B6p%C3%B6%20-%20Website%20visuals/Icons/carbon_logo-linkedin-grey.svg) ![Email](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/H%C3%B6p%C3%B6h%C3%B6p%C3%B6%20-%20Website%20visuals/Icons/Sign-At--Streamline-Core.svg)

Non-Executive Director & Chair of Audit & Risk Committee

Abbas Hussain

![LinkedIn](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/H%C3%B6p%C3%B6h%C3%B6p%C3%B6%20-%20Website%20visuals/Icons/carbon_logo-linkedin-grey.svg) ![Email](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/H%C3%B6p%C3%B6h%C3%B6p%C3%B6%20-%20Website%20visuals/Icons/Sign-At--Streamline-Core.svg)

Principal

Natalie Johnston

![LinkedIn](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/H%C3%B6p%C3%B6h%C3%B6p%C3%B6%20-%20Website%20visuals/Icons/carbon_logo-linkedin-grey.svg) ![Email](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/H%C3%B6p%C3%B6h%C3%B6p%C3%B6%20-%20Website%20visuals/Icons/Sign-At--Streamline-Core.svg)

Managing Partner, Co-Founder

Andrew Kozlov

![LinkedIn](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/H%C3%B6p%C3%B6h%C3%B6p%C3%B6%20-%20Website%20visuals/Icons/carbon_logo-linkedin-grey.svg) ![Email](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/H%C3%B6p%C3%B6h%C3%B6p%C3%B6%20-%20Website%20visuals/Icons/Sign-At--Streamline-Core.svg)

Managing Partner

Dima Kuzmin

![LinkedIn](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/H%C3%B6p%C3%B6h%C3%B6p%C3%B6%20-%20Website%20visuals/Icons/carbon_logo-linkedin-grey.svg) ![Email](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/H%C3%B6p%C3%B6h%C3%B6p%C3%B6%20-%20Website%20visuals/Icons/Sign-At--Streamline-Core.svg)

## How to approach funds like 4BIO Capital

 When approaching 4BIO Capital, founders should highlight the scientific rigor and translational potential of their technology, demonstrating clear differentiation in the advanced therapies landscape. Articulate how your team’s expertise and data-driven milestones align with the path to clinical validation and regulatory approval. Emphasize your strategy for addressing significant unmet medical needs and your plan for scalable patient access, as 4BIO values both scientific depth and real-world impact.

## Find the best-fitting investors for your startup

 Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing. 

[Find your investor matches](https://start.hopohopo.io/?signup=true)

![Investor funnel board](https://www.hopohopo.io/hubfs/Investor%20list%20web%20page%201.png)

[Check the next investor profile](https://www.hopohopo.io/investors/new-vision-3?hsLang=io)

×

![Hopohopo logo](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/HO-Logo_favicon.png)

## Check your match score in Hopohopo.io

 Check how well 4BIO Capital fits your startup and get a list of the best-fitting investors for your fundraising. 

[Sign up](https://start.hopohopo.io/?signup=true)

×

![Hopohopo logo](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/HO-Logo_favicon.png)

## Check 4BIO Capital contact details in Hopohopo.io

 Browse all of the contacts related to 4BIO Capital and send emails directly from your funnel. 

[Sign up](https://start.hopohopo.io/?signup=true)

- [For Startups](https://www.hopohopo.io/startups?hsLang=io)
- [For Investors and Accelerators](https://www.hopohopo.io/business-angels-and-vcs?hsLang=io)
- [For Business Angel Networks](https://www.hopohopo.io/business-angel-networks?hsLang=io)

- [Blog](https://hopohopo.gitbook.io/fundraising-with-hopohopo/)

### Follow us

<https://www.linkedin.com/company/hopohopo-io>

![Höpöhöpö_logo_white](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/H%C3%B6p%C3%B6h%C3%B6p%C3%B6_logo_white.png)

© 2026 Hopohopo.io All rights reserved

[Privacy Policy](https://www.hopohopo.io/privacy-policy?hsLang=io)  
[Terms of Service](https://www.hopohopo.io/terms-of-service?hsLang=io) 

![](https://px.ads.linkedin.com/collect/?pid=4090745&fmt=gif)

```json
{
  "@context" : "https://schema.org",
  "@type" : "Organization",
  "description" : "4BIO Capital is a London-based venture capital firm focused solely on the advanced therapies sector. The firm aims to invest in, support, and grow early-stage companies developing treatments in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially curative therapies for all patients. Specifically, 4BIO Capital seeks opportunities in cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome. The team comprises leading advanced therapy scientists and experienced life science investors who have collectively published over 250 scientific articles in prestigious academic journals, including Nature, The Lancet, Cell, and the New England Journal of Medicine. This expertise provides 4BIO with an unrivaled network within the advanced therapy sector and a unique understanding of the criteria that define a successful investment opportunity in this space.",
  "logo" : "https://148519842.fs1.hubspotusercontent-eu1.net/hubfs/148519842/ecosystem-logos-from-platform/7507-1a706f5847b2724986a7f0064a0fef32.jpeg",
  "name" : "4BIO Capital",
  "sameAs" : [ "", "" ],
  "url" : "http://www.4biocapital.com"
}
```